EVH
Evolent Health, Inc.NYSEHealthcare$2.25+1.35%ClosedMarket Cap: $251.2M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.62
P/S
0.13
EV/EBITDA
-3.01
DCF Value
$-310.01
FCF Yield
1.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
15.1%
Operating Margin
-0.6%
Net Margin
-28.5%
ROE
-69.2%
ROA
-86.2%
ROIC
-0.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $468.7M | -4.2% | $-9.6M | $-429.1M | $-3.76 | — |
| FY 2025 | $1.88B | 15.1% | $-4.4M | $-534.5M | $-5.07 | — |
| Q3 2025 | $479.5M | 20.8% | $886.0K | $-20.9M | $-0.24 | — |
| Q2 2025 | $444.3M | 22.6% | $-1.2M | $-19.9M | $-0.44 | — |
| Q1 2025 | $483.6M | 21.2% | $-1.6M | $-64.6M | $-0.63 | — |
| Q4 2024 | $646.5M | 11.7% | $-18.6M | $-22.8M | $-0.27 | — |
| FY 2024 | $2.55B | 14.4% | $-40.5M | $-61.6M | $-0.81 | — |
| Q3 2024 | $621.4M | 13.0% | $-16.3M | $-23.1M | $-0.27 | — |
| Q2 2024 | $647.1M | 16.5% | $7.8M | $1.6M | $-0.06 | — |
| Q1 2024 | $639.7M | 16.3% | $-13.4M | $-17.3M | $-0.22 | — |
| Q4 2023 | $556.1M | 18.3% | $-21.4M | $-33.4M | $-0.36 | — |
| FY 2023 | $1.96B | 23.4% | $-71.2M | $-113.0M | $-1.28 | — |